BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18346015)

  • 1. Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process.
    Qiu Y; Shi L; Wang Y; Zhang G; Zheng J; Gong X; Xia H; Zhang P; Ness P; Shan H
    Transfusion; 2008 Jun; 48(6):1207-12. PubMed ID: 18346015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE
    J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.
    López RA; Romero-Estrella S; Infante-Ramírez L; Méndez-Aquino JS; Berrón-Ruiz P; Morales-Alfaro NA; Vivar R; Carrada E; Rivera-Rendón Mdel R; Sánchez-Guerrero SA
    Transfusion; 2004 Sep; 44(9):1344-9. PubMed ID: 15318859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
    Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE
    Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of and risk factors for hepatitis C in blood donors].
    Ladrón-de Guevara L; Gómez N; Vázquez-Cantarell M; García-Méndez S; Di Silvio M
    Rev Gastroenterol Mex; 2002; 67(1):11-6. PubMed ID: 12066425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cross-sectional survey on hepatitis C virus infection among residents aged 18-59 years in a former commercial blood donating community, Shanxi Province].
    Shi XM; Mei ZQ; Gao JH; Qiao XC; Qian HZ; Jia WQ; Yang ZM; Zhang YL; Zheng XW; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):864-7. PubMed ID: 16676606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    He Y; Zhang J; Zhong L; Chen X; Liu HM; Wan LK; Wang H; Li H; Tian L; Hu JL; Luo P; Wang L; Chen Y; Liu T; Liu SL; Lü WB
    J Med Virol; 2011 Apr; 83(4):616-21. PubMed ID: 21328375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).
    Murphy EL; Bryzman SM; Glynn SA; Ameti DI; Thomson RA; Williams AE; Nass CC; Ownby HE; Schreiber GB; Kong F; Neal KR; Nemo GJ
    Hepatology; 2000 Mar; 31(3):756-62. PubMed ID: 10706569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hepatitis C virus infection among blood donors in Israel: a case-control study between native Israelis and immigrants from the former Soviet Union.
    Kerzman H; Green MS; Shinar E
    Transfusion; 2007 Jul; 47(7):1189-96. PubMed ID: 17581153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
    Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
    Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study.
    Tanwandee T; Piratvisuth T; Phornphutkul K; Mairiang P; Permpikul P; Poovorawan Y
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S79-83. PubMed ID: 17722300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
    Tang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.